US 12213985
Oral cannabinoid formulations
granted A61KA61K31/05A61K31/658
Quick answer
US patent 12213985 (Oral cannabinoid formulations) held by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/05, A61K31/658, A61K47/10, A61K47/14